Core Insights - Yuyue Medical (002223.SZ) is enhancing its health management ecosystem by integrating its AI Agent application with the "Yuyue Health Manager" platform, allowing various medical devices to connect and improve user experience [1][3] Group 1: Product Integration - The company currently offers several models of blood glucose meters, blood pressure monitors, pulse oximeters, ventilators, and oxygen concentrators that can connect to the "Yuyue Health Manager" [1] - Future upgrades and iterations of the AI Agent application will focus on creating a more integrated health management system [1] Group 2: User Feedback and Functionality - Investors have expressed interest in the range of devices supported by the new "Yuyue Health Manager" app, suggesting that it should include more Yuyue products beyond just CGM and blood pressure monitors [3] - There are concerns regarding the AI used for health services, questioning whether it is developed in-house or sourced from other internet AI, and suggesting improvements in health knowledge sharing [3]

Core Viewpoint - The company is integrating cutting-edge technologies like artificial intelligence into the development of its Continuous Glucose Monitoring (CGM) products, focusing on wearable medical devices for health management [2] Group 1: Product Development - The company is actively engaged in the research and development of AI-powered wearable medical devices [2] - There is an emphasis on the professional positioning of wearable products in the health sector, aiming to create products with brand characteristics and differentiated competitiveness [2] Group 2: Ecosystem Integration - The company is upgrading the Fish Leap AIAgent application to integrate with the existing "Fish Leap Health Manager" platform [2] - This integration aims to better connect users with current and future products, creating a comprehensive health management ecosystem [2]